Brege Laura
CIK 0001365619
Director
Filings
24
Latest Jun 1, 2026
Issuers covered
4
Showing
24 of 24
Page 1
Track record
8 of 8 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 50% | +0.5% | +1.7% | +5.0% | -5.1% |
| 90 days | 8 | 63% | +5.1% | +6.5% | +26.5% | -18.0% |
| 180 days | 8 | 50% | +11.1% | +0.1% | +109.7% | -35.6% |
| 365 days | 6 | 83% | +21.1% | +26.0% | +92.3% | -56.7% |
Issuers
Companies where Brege Laura has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACAD | Acadia Pharmaceuticals Inc | 8 | Jun 1, 2026 |
| PCRX | Pacira Biosciences, Inc. | 7 | Jun 13, 2025 |
| MIRM | Mirum Pharmaceuticals, Inc. | 5 | Sep 12, 2025 |
| EWTX | Edgewise Therapeutics, Inc. | 4 | Jun 18, 2025 |
All filings
24 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|